聯亞藥業

301569
16.044.12% ( -0.69 )
延遲 交易中: 11月18日 14:00:12

股東

全部股東

股東類型

  • 創投/私募41.35%
  • 私人企業32.11%
  • 個人與內幕人士11.27%
  • 機構投資者9.24%
  • 僱員持股計劃6.04%

主要股東

主要股東 最新
股東
Legend Capital Management Co., Ltd.
19.71%1.76 億--+1.76 億15/10/2026
Novast Holdings, Ltd.
19.23%1.71 億--+1.71 億15/10/2026
Hainan Shiyu Investment Management Co., Ltd.
12.71%1.13 億--+1.13 億15/10/2026
Hui Wang
11.18%9,971.76 萬--+9,971.76 萬15/10/2026
Xiamen C&D Emerging Industry Equity Investment Co., Ltd.
11.05%9,848.93 萬--+9,848.93 萬15/10/2026
Xiamen Jianfa Emerging Industries Equity Investment Partnership No. 8 (Limited Partnership)
11.05%9,848.93 萬--+9,848.93 萬15/10/2026
China Merchants Capital Management Co., Ltd.
4.62%4,115.97 萬--+4,115.97 萬15/10/2026
China Merchants Capital Investment Co., Ltd.
4.62%4,115.97 萬--+4,115.97 萬15/10/2026
Jiaxing Xuanyu Equity Investment Partnership (Limited Partnership)
3.47%3,097.36 萬--+3,097.36 萬15/10/2026
Nantong Lianbo Enterprise Management Partnership (Limited Partnership)
2.10%1,870.18 萬--+1,870.18 萬15/10/2026
Nantong Lianjia Enterprise Management Partnership (Limited Partnership)
1.08%964.68 萬--+964.68 萬15/10/2026
Nantong Lianji Enterprise Management Partnership (Limited Partnership)
1.02%905.93 萬--+905.93 萬15/10/2026
Nantong Lianxi Enterprise Management Partnership (Limited Partnership)
0.95%849.59 萬--+849.59 萬15/10/2026
Nantong Lianmeng Enterprise Management Partnership (Limited Partnership)
0.70%621.68 萬--+621.68 萬15/10/2026
Lin Liu
0.66%588.00 萬--+588.00 萬15/10/2026
CICC Lianyao Pharmaceuticals No. 1 Employee Asset Management Plan
0.50%447.14 萬--+447.14 萬15/10/2026
Hubei Jiuzhoutong Gaotou Changjiang Industrial Investment Fund Management Co., Ltd.
0.48%428.57 萬--+428.57 萬15/10/2026